Related content

Luteinizing Hormone-Releasing Hormone Analogue-Induced Cataract in a Patient with Prostate Cancer

By  

Medical Principles and Practice, Vol. 16, Iss. 2, 2007-02 ,pp. : 161-163

Karger

Access to resources Recommend Favorite

Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone

By Weissman A  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3421-3424

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite

Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose

By Buckett WM  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 811-814

Oxford University Press

Access to resources Recommend Favorite

The cellular activity of different sized follicles in cycles treated with gonadotrophin-releasing hormone analogue.

By Andreani C L   Diotallevi L   Lazzarin N   Pierro E   Giannini P   Lanzone A   Capitanio P   Mancuso S  

Human Reproduction, Vol. 12, Iss. 1, 1997-01 ,pp. : 89-94

Oxford University Press

Access to resources Recommend Favorite